Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Submitted by
admin
on October 9, 2012 - 9:55am
Source:
Seeking Alpha
News Tags:
obesity
Novo Nordisk
Merck
Bristol-Myers Squibb
diabetes
Sanofi
Headline:
Novo Nordisk Is Positioned To Profit Off Of Obesity Epidemic But Price May Be Rich
Do Not Allow Advertisers to Use My Personal information
